Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Antibiotic resistance in hospitals
- Antibiotic resistance in the community
- The pre-antibiotic era
- The first antibiotics
- Penicillin (1)
- Penicillin (2)
- Penicillin - structure
- Tuberculosis
- Streptomycin
- Trials of streptomycin
- Streptococcus pneumoniae (1)
- Streptococcus pneumoniae (2)
- Multidrug resistant pneumococci
- Multidrug resistant clones
- Staphylococcus aureus
- S. aureus disease
- Spread of MRSA
- MRSA bacteraemia as % in blood cultures
- European distribution of MRSA
- Increasing resistance
- Worldwide MRSA prevalence
- Treatment of MRSA
- The benefits of antibiotics
- The extent of resistance in the UK
- Causes of resistance - mutation
- Causes of resistance - gene transfer
- Increased use leads to more resistance
- Antibiotic classes - beta-lactams
- Antibiotic classes - glycopeptides
- Antibiotic classes - Aminoglycosides
- Antibiotic classes - Fluoroquinolones
- Antibiotic classes - Macrolides
- Antibiotic classes- trimethoprim and tetracyclines
- Other antibiotic classes
- Antibiotic agents in the community and hospitals
- Antimicrobial use and selection for resistance
- The threat
- Implications of inappropriate antibacterial therapy
- Why no new antibiotics?
Topics Covered
- Antibiotic resistance in hospitals
- Antibiotic resistance in the community
- The pre-antibiotic era
- Penicillin
- Tuberculosis
- Streptomycin
- Streptococcus pneumoniae
- Multidrug resistant pneumococci
- Staphylococcus aureus
- Spread of MRSA
- European and worldwide distribution of MRSA
- Treatment of MRSA
- The benefits of antibiotics
- The extent of bacterial resistance in the UK
- Causes of resistance
- Antibiotic classes
- The pyramids for antimicrobial use and selection for antimicrobial resistance
- The threat
- Why no new antibiotics?
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Enright, M. (2009, December 31). Methicillin resistant S. aureus and other resistances [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 12, 2024, from https://doi.org/10.69645/EEYY5947.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Mark Enright has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.